MICROINJECTION OF CHOLECYSTOKININ INTO THE RAT VENTRAL TEGMENTAL AREA POTENTIATES DOPAMINE-INDUCED HYPOLOCOMOTION

被引：37

作者：

CRAWLEY, JN

机构：

来源：

SYNAPSE | 1989年 / 3卷 / 04期

关键词：

D O I：

10.1002/syn.890030408

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

引用

收藏

页码：346 / 355

页数：10

相关论文

共 42 条

[1] CHOLECYSTOKININ POTENTIATES DOPAMINE-INHIBITION OF MESENCEPHALIC DOPAMINE NEURONS INVITRO
BRODIE, MS
DUNWIDDIE, TV
[J]. BRAIN RESEARCH, 1987, 425 (01) : 106 - 113
[2] BIOCHEMICAL AND PHARMACOLOGICAL CHARACTERIZATION OF AN EXTREMELY POTENT AND SELECTIVE NONPEPTIDE CHOLECYSTOKININ ANTAGONIST
CHANG, RSL
LOTTI, VJ
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (13) : 4923 - 4926
[3] DIFFERENTIATION OF DOPAMINE MECHANISMS MEDIATING STEREOTYPED BEHAVIOR AND HYPERACTIVITY IN NUCLEUS ACCUMBENS AND CAUDATE-PUTAMEN
COSTALL, B
NAYLOR, RJ
CANNON, JG
LEE, T
[J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1977, 29 (06) : 337 - 342
[4] CRAWLEY JN, 1985, J NEUROSCI, V5, P1972
[5] TOPOGRAPHICAL ANALYSIS OF NUCLEUS ACCUMBENS SITES AT WHICH CHOLECYSTOKININ POTENTIATES DOPAMINE-INDUCED HYPERLOCOMOTION IN THE RAT
CRAWLEY, JN
HOMMER, DW
SKIRBOLL, LR
[J]. BRAIN RESEARCH, 1985, 335 (02) : 337 - 341
[6] CRAWLEY JN, 1986, J PHARMACOL EXP THER, V236, P320
[7] CRAWLEY JN, 1988, MESOCORTICOLIMBIC DO, V537, P380
[8] DAHLSTROM A, 1964, ACTA PHYSIOL SCAND, V62, P1
[9] ENHANCEMENT OF MORPHINE ANALGESIA AND PREVENTION OF MORPHINE-TOLERANCE IN THE RAT BY THE CHOLECYSTOKININ ANTAGONIST L-364,718
DOURISH, CT
HAWLEY, D
IVERSEN, SD
[J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 147 (03) : 469 - 472
[10] DOPAMINE RECEPTOR ELEVATION BY CHOLECYSTOKININ
DUMBRILLEROSS, A
SEEMAN, P
[J]. PEPTIDES, 1984, 5 (06) : 1207 - 1212

← 1 2 3 4 5 →